Current Status of Diagnosis and Treatment of Uroepithelial Carcinoma

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

NCT02379429 ·Status: RECRUITING

The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer

NCT07252297 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors

NCT06490211 ·Status: RECRUITING

The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients

NCT06245759 ·Status: RECRUITING

A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up

NCT04432909 ·Status: UNKNOWN

The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma

NCT06564363 ·Status: RECRUITING

Effect of Tumor Base Size in Bladder Cancer

NCT06632340 ·Status: COMPLETED ·Phase: NA

Establishment and Validation of an Early Diagnostic Model for Bladder Cancer Based on Serum and Urine Metabolomics

NCT04966962 ·Status: UNKNOWN

Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma

NCT02788201 ·Status: COMPLETED ·Phase: PHASE2

Multi-parametric MRI in Patients of Bladder Cancer

NCT06362330 ·Status: RECRUITING

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

NCT07036731 ·Status: RECRUITING ·Phase: NA

Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer

NCT06775977 ·Status: RECRUITING

Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder

NCT05077852 ·Status: UNKNOWN

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

NCT04923178 ·Status: RECRUITING

Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic

NCT04770974 ·Status: UNKNOWN

Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After Neoadjuvant Chemotherapy

NCT04966975 ·Status: UNKNOWN

The Application Value of Artificial Intelligence in MRI Precision Diagnosis and Treatment of Bladder Cancer

NCT05096533 ·Status: UNKNOWN

Prognostic Biomarkers in Patients With Urothelial Carcinoma

NCT04872036 ·Status: COMPLETED

Development and Prospective Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the Efficacy of Neoadjuvant Treatment of Bladder Cancer

NCT06909643 ·Status: RECRUITING

AI Detection of Bladder Tumors Under Endoscopy

NCT06474338 ·Status: RECRUITING

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

NCT03788746 ·Status: COMPLETED

Urine Omics Predicting IO Therapy Responses in mUC Patients

NCT04641936 ·Status: RECRUITING

Research on the Accurate Diagnosis of Urinary Tract Tumors and the Development of Kits

NCT06193941 ·Status: COMPLETED

Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma

NCT00867620 ·Status: UNKNOWN

Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma

NCT04314245 ·Status: COMPLETED